Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis

C. Machahua (L'Hospitalet de Llobregat, Spain), A. Montes-Worboys (L'Hospitalet de Llobregat, Spain), L. Planas-Cerezales (L'Hospitalet de Llobregat, Spain), R. Buendia-Flores (L'Hospitalet de Llobregat, Spain), M. Molina-Molina (L'Hospitalet de Llobregat, Spain), V. Vicens-Zygmunt (L'Hospitalet de Llobregat, Spain)

Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Machahua (L'Hospitalet de Llobregat, Spain), A. Montes-Worboys (L'Hospitalet de Llobregat, Spain), L. Planas-Cerezales (L'Hospitalet de Llobregat, Spain), R. Buendia-Flores (L'Hospitalet de Llobregat, Spain), M. Molina-Molina (L'Hospitalet de Llobregat, Spain), V. Vicens-Zygmunt (L'Hospitalet de Llobregat, Spain). Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis. 3708

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016
Year: 2017



Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Role of MUC4 in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

Role of MUC4 in idiopathic pulmonary fibrosis
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018

Differential diagnosis of pulmonary eosinophilia
Source: Eur Respir Monogr 2022; 95: 19-36
Year: 2022


Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2015 – IPF pathogenesis
Year: 2015



Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013

Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Role of midkine in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
Source: Annual Congress 2004 - Fibrosing lung diseases
Year: 2004


Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Pathogenesis of pulmonary fibrosis in sarcoidosis
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020


Role of BALF in differential diagnosis of smoking related interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006